Shared decision-making before prostate cancer screening decisions

被引:0
|
作者
Pekala, Kelly R. [1 ]
Shill, Daniela K. [2 ]
Austria, Mia [3 ]
Langford, Aisha T. [4 ]
Loeb, Stacy [5 ,6 ]
Carlsson, Sigrid V. [1 ,3 ,7 ,8 ,9 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[4] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Sch Med, Detroit, MI USA
[5] NYU, Dept Populat Hlth, New York, NY USA
[6] NYU, Dept Urol, New York, NY USA
[7] Manhattan Vet Affairs Med Ctr, New York, NY 10010 USA
[8] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Urol, Gothenburg, Sweden
[9] Lund Univ, Med Fac, Dept Translat Med, Div Urol Canc, Lund, Sweden
基金
美国国家卫生研究院;
关键词
RACIAL DISPARITIES; MEN; CONFLICT; LITERACY; PATTERNS; PSA;
D O I
10.1038/s41585-023-00840-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Decisions around prostate-specific antigen screening require a patient-centred approach, considering the benefits and risks of potential harm. Using shared decision-making (SDM) can improve men's knowledge and reduce decisional conflict. SDM is supported by evidence, but can be difficult to implement in clinical settings. An inclusive definition of SDM was used in order to determine the prevalence of SDM in prostate cancer screening decisions. Despite consensus among guidelines endorsing SDM practice, the prevalence of SDM occurring before the decision to undergo or forgo prostate-specific antigen testing varied between 11% and 98%, and was higher in studies in which SDM was self-reported by physicians than in patient-reported recollections and observed practices. The influence of trust and continuity in physician-patient relationships were identified as facilitators of SDM, whereas common barriers included limited appointment times and poor health literacy. Decision aids, which can help physicians to convey health information within a limited time frame and give patients increased autonomy over decisions, are underused and were not shown to clearly influence whether SDM occurs. Future studies should focus on methods to facilitate the use of SDM in clinical settings. In this Review, the authors discuss shared decision-making for prostate cancer screening in terms of definition, prevalence and methods, including decision aids. Facilitators and barriers to shared decision-making are also discussed. Shared decision-making (SDM) about prostate-specific antigen screening should be collaborative between patients and physicians, and should consist of eliciting patients' preferences, providing evidence-based information about risks and benefits, and reaching a values-concordant choice.The use of SDM for prostate cancer screening is suggested by guideline groups, but SDM remains underused.Facilitators to SDM include a consistent clinician-provider relationship, trust in the clinician, having a partner, and high education level.Barriers to SDM include limited appointment times, insufficient knowledge, poor health literacy, any barrier to communication, and physician beliefs about screening.Decision aids can help to improve patients' knowledge and facilitate SDM, but are rarely used in clinical practice.
引用
收藏
页码:329 / 338
页数:10
相关论文
共 50 条
  • [1] Prostate Cancer Screening Shared Decision-Making for Screening and Treatment
    Blackwelder, Russ
    Chessman, Alexander
    [J]. PRIMARY CARE, 2019, 46 (01): : 149 - +
  • [2] Disparities Associated with Shared Decision-making in Prostate Cancer Screening
    Basin, Michael F.
    Crane, Kelly
    Basnet, Alina
    Chandrasekar, Thenappan
    Shapiro, Oleg
    Jacob, Joseph M.
    Bratslavsky, Gennady
    Goldberg, Hanan
    [J]. EUROPEAN UROLOGY FOCUS, 2023, 9 (06): : 1008 - 1015
  • [3] DISPARITIES REGARDING SHARED DECISION-MAKING IN PROSTATE CANCER SCREENING
    Basin, Michael
    Basnet, Alina
    Shapiro, Oleg
    Jacob, Joseph
    Bratslavsky, Gennady
    Goldberg, Hanan
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E339 - E340
  • [4] Impact of the shared decision-making process on lung cancer screening decisions
    Tan, Naomi Q. P.
    Nishi, Shawn P. E.
    Lowenstein, Lisa M.
    Mendoza, Tito R.
    Lopez-Olivo, Maria A.
    Crocker, Laura C.
    Sepucha, Karen R.
    Volk, Robert J.
    [J]. CANCER MEDICINE, 2022, 11 (03): : 790 - 797
  • [5] Evaluation of the shared decision-making process scale in cancer screening and medication decisions
    Vo, Ha
    Valentine, K. D.
    Barry, Michael J.
    Sepucha, Karen R.
    [J]. PATIENT EDUCATION AND COUNSELING, 2023, 108
  • [6] Shared Decision-Making for Lung Cancer Screening
    Nishi, Shawn P. E.
    Lowenstein, Lisa M.
    Mendoza, Tito R.
    Lopez, Maria A.
    Crocker, Laura C.
    Sepucha, Karen
    Niu, Jiangong
    Volk, Robert J.
    [J]. CHEST, 2021, 160 (01) : 330 - 340
  • [7] Prevalence of Shared Decision-making in Prostate Cancer Screening in New York State
    Lindsey J. Mattick
    Kofi Biney
    Heather M. Dacus
    Gina M. O’Sullivan
    Heather M. Ochs-Balcom
    [J]. Journal of Immigrant and Minority Health, 2023, 25 : 1207 - 1210
  • [8] PROSTATE CANCER SCREENING: IMPLEMENTATION OF A SHARED DECISION-MAKING TOOL FOR PATIENT CONVERSATIONS
    Killeen, Colin
    Misra-Hebert, Anita D.
    Goto, Toyomi
    Fox, Jacqueline
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S683 - S684
  • [9] Prevalence of Shared Decision-making in Prostate Cancer Screening in New York State
    Mattick, Lindsey J.
    Biney, Kofi
    Dacus, Heather M.
    O'Sullivan, Gina M.
    Ochs-Balcom, Heather M.
    [J]. JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 2023, 25 (05) : 1207 - 1210
  • [10] "Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?
    Golijanin, Borivoj
    Bhatt, Vikas
    Homer, Alexander
    Malshy, Kamil
    Ochsner, Anna
    Wales, Rebecca
    Khaleel, Sari
    Mega, Anthony
    Pareek, Gyan
    Hyams, Elias
    [J]. CANCER EPIDEMIOLOGY, 2024, 88